Table 2:
Year of the transplant | |
1998–2000 | 8/52 (15%) |
2001–2006 | 44/52 (85%) |
Donor | |
HLA matched sibling | 39/52 (75%) |
Unrelated or HLA “mismatched” sibling | 13/52 (25%) |
Source | |
Bone marrow | 18/52 (35%) |
Peripheral blood | 34/52 (65%) |
Conditioning regimen | |
Fludarabine plus busulphan | 14/52 (27%) |
Thiotepa plus cyclophosphamide | 24/52 (46%) |
Fludarabine- 2 Gy TBI | 4/52 (8%) |
Fludarabine-melphalan | 6/52 (11%) |
Other | 4/52 (8%) |